ea0081ep74 | Adrenal and Cardiovascular Endocrinology | ECE2022
Sorushanova Anna
, Donlon Padraig
, Covarrubias-Zambrano Obdulia
, Covarrubias Jose
, Varghese Sunitha
, Owens Peter
, O'Halloran Martin
, Prakash Punit
, Bossmann Stefan
, Dennedy Michael Conall
To minimise damage to surrounding tissues, targeted delivery of therapeutics to the tumour is highly desirable, and the development of nanotechnology has shown promising results. Magnetic iron oxide nanoparticles (MIONPs) have been gaining traction over the years for applications such as drug delivery, molecular imaging and delivering hyperthermia for treatment of various cancers (1). MIONPs have great therapeutic potential as they can be produced in various sizes and shapes, ...